Harriet L.S. Lawford , ‘Ofa Tukia , Joseph Takai , Sarah Sheridan , Selina Ward , Holly Jian , Beatris Mario Martin , Reynold ‘Ofanoa , Colleen L. Lau
{"title":"Persistent lymphatic filariasis transmission seven years after validation of elimination as a public health problem: a cross-sectional study in Tonga","authors":"Harriet L.S. Lawford , ‘Ofa Tukia , Joseph Takai , Sarah Sheridan , Selina Ward , Holly Jian , Beatris Mario Martin , Reynold ‘Ofanoa , Colleen L. Lau","doi":"10.1016/j.lanwpc.2025.101513","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The World Health Organization (WHO) has validated 21 countries as having eliminated lymphatic filariasis (LF) as a public health problem. Post-validation surveillance (PVS) is required in countries where LF has been eliminated. Tonga eliminated LF in 2017, but no PVS strategy has been established. We aimed to identify any persistent LF transmission in Tonga in 2024 and provide evidence to support a PVS strategy.</div></div><div><h3>Methods</h3><div>A four-pronged, targeted, cross-sectional study was conducted in the Tongan districts of Tongatapu, Ha’apai, and Ongo Niuas in May–July 2024 in communities, primary schools, high schools, and an outpatient clinic. Participants were tested for LF antigen (Ag) and microfilariae (Mf). The outcome measure for persistent LF transmission was Ag-positivity.</div></div><div><h3>Findings</h3><div>Between 9 May and 19 July 2024, 1787 participants were recruited from 12 communities, 11 primary schools, five high schools, and one outpatient clinic. Overall, 39 participants (2·2%) were Ag-positive and five (0·3%) were Mf-positive. The highest Ag prevalence was in communities (4·0%; 95% confidence interval [95%CI]: 2·9–5·6), where all Mf-positives (n = 5) were identified. Ag-positivity was associated with male sex (adjusted odds ratio [aOR]:4·86; 95%CI: 2·25–10·46), older age (>50 years vs 5–10 years [aOR:7·51; 95%CI: 2·13–26·47]), and residing in Ha’apai (aOR:15·08; 95%CI: 5·41–42·05) and Ongo Niuas (aOR:10·85; 95%CI: 3·91–30·08).</div></div><div><h3>Interpretation</h3><div>We found persistent LF transmission in Tonga seven years post-validation. Community surveillance yielded the highest Ag and Mf prevalence. Efficiency of PVS could be improved by integrating surveillance activities into the existing health system and conducting community-based surveys, particularly among older males and in high prevalence areas.</div></div><div><h3>Funding</h3><div><span>Task Force for Global Health</span>, <span>Bill & Melinda Gates Foundation</span>, and the <span>United States Agency for International Development</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"57 ","pages":"Article 101513"},"PeriodicalIF":7.6000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666606525000501","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The World Health Organization (WHO) has validated 21 countries as having eliminated lymphatic filariasis (LF) as a public health problem. Post-validation surveillance (PVS) is required in countries where LF has been eliminated. Tonga eliminated LF in 2017, but no PVS strategy has been established. We aimed to identify any persistent LF transmission in Tonga in 2024 and provide evidence to support a PVS strategy.
Methods
A four-pronged, targeted, cross-sectional study was conducted in the Tongan districts of Tongatapu, Ha’apai, and Ongo Niuas in May–July 2024 in communities, primary schools, high schools, and an outpatient clinic. Participants were tested for LF antigen (Ag) and microfilariae (Mf). The outcome measure for persistent LF transmission was Ag-positivity.
Findings
Between 9 May and 19 July 2024, 1787 participants were recruited from 12 communities, 11 primary schools, five high schools, and one outpatient clinic. Overall, 39 participants (2·2%) were Ag-positive and five (0·3%) were Mf-positive. The highest Ag prevalence was in communities (4·0%; 95% confidence interval [95%CI]: 2·9–5·6), where all Mf-positives (n = 5) were identified. Ag-positivity was associated with male sex (adjusted odds ratio [aOR]:4·86; 95%CI: 2·25–10·46), older age (>50 years vs 5–10 years [aOR:7·51; 95%CI: 2·13–26·47]), and residing in Ha’apai (aOR:15·08; 95%CI: 5·41–42·05) and Ongo Niuas (aOR:10·85; 95%CI: 3·91–30·08).
Interpretation
We found persistent LF transmission in Tonga seven years post-validation. Community surveillance yielded the highest Ag and Mf prevalence. Efficiency of PVS could be improved by integrating surveillance activities into the existing health system and conducting community-based surveys, particularly among older males and in high prevalence areas.
Funding
Task Force for Global Health, Bill & Melinda Gates Foundation, and the United States Agency for International Development.
期刊介绍:
The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.